hrd insight
Cancer ScreeningBlood sampleResults 14-21 daysNo fasting
HRD Insight
A genomic test that measures homologous recombination deficiency (HRD), a feature of certain tumours that affects how well they respond to specific cancer therapies. It is often used to help guide treatment decisions in cancers such as ovarian cancer.
Sample
Blood
Results
14-21 days
Fasting
Not required
Follow-up
Optional add-on
What this test detects
Homologous recombination deficiency (HRD) status
Next-generation sequencing
Positive / negative status
Genomic instability score
Next-generation sequencing
Quantitative score
BRCA1/BRCA2 variants
Next-generation sequencing
Mutation status
When to get this test
Guiding targeted therapy
Helps identify patients who may benefit from PARP inhibitor treatment.
Ovarian and related cancers
Commonly used in ovarian, fallopian tube, and primary peritoneal cancers to inform management.
Personalised treatment planning
Provides genomic information that supports individualised cancer care decisions.
How to prepare
01
No special preparation needed.
02
Bring any relevant pathology or prior test reports if available.
Common questions
How long do results take?
Results are typically ready within 14 to 21 days because of the detailed genomic analysis involved.
Do I need to fast?
No fasting is required for this test.
Who is this test for?
It is generally ordered for patients with certain cancers to help guide treatment, usually as recommended by their care team.